192 related articles for article (PubMed ID: 29272108)
21. Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors.
Legina MS; Nogueira JJ; Kandioller W; Jakupec MA; González L; Keppler BK
J Biol Inorg Chem; 2020 May; 25(3):451-465. PubMed ID: 32193613
[TBL] [Abstract][Full Text] [Related]
22. Effects of Olive Metabolites on DNA Cleavage Mediated by Human Type II Topoisomerases.
Vann KR; Sedgeman CA; Gopas J; Golan-Goldhirsh A; Osheroff N
Biochemistry; 2015 Jul; 54(29):4531-41. PubMed ID: 26132160
[TBL] [Abstract][Full Text] [Related]
23. Salicylate, a catalytic inhibitor of topoisomerase II, inhibits DNA cleavage and is selective for the α isoform.
Bau JT; Kang Z; Austin CA; Kurz EU
Mol Pharmacol; 2014 Feb; 85(2):198-207. PubMed ID: 24220011
[TBL] [Abstract][Full Text] [Related]
24. 4,6-Substituted-1,3,5-triazin-2(1H)-ones as monocyclic catalytic inhibitors of human DNA topoisomerase IIα targeting the ATP binding site.
Pogorelčnik B; Janežič M; Sosič I; Gobec S; Solmajer T; Perdih A
Bioorg Med Chem; 2015 Aug; 23(15):4218-4229. PubMed ID: 26183545
[TBL] [Abstract][Full Text] [Related]
25. Increasing the distance between two monomers of topoisomerase IIβ under the action of antitumor agent 4β-sulfur-(benzimidazole) 4'-demethylepipodophyllotoxin.
Sun LY; Zhu LW; Tang YJ
Sci Rep; 2018 Oct; 8(1):14949. PubMed ID: 30297860
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in the development of catalytic inhibitors of human DNA topoisomerase IIα as novel anticancer agents.
Pogorelčnik B; Perdih A; Solmajer T
Curr Med Chem; 2013; 20(5):694-709. PubMed ID: 23210851
[TBL] [Abstract][Full Text] [Related]
27. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.
McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N
Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267
[TBL] [Abstract][Full Text] [Related]
28. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.
Dickey JS; Osheroff N
Biochemistry; 2005 Aug; 44(34):11546-54. PubMed ID: 16114891
[TBL] [Abstract][Full Text] [Related]
29. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
Bender RP; Osheroff N
Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
[TBL] [Abstract][Full Text] [Related]
30. Polychlorinated biphenyl quinone metabolites poison human topoisomerase IIalpha: altering enzyme function by blocking the N-terminal protein gate.
Bender RP; Lehmler HJ; Robertson LW; Ludewig G; Osheroff N
Biochemistry; 2006 Aug; 45(33):10140-52. PubMed ID: 16906772
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors.
Han X; Zhong Y; Zhou G; Qi H; Li S; Ding Q; Liu Z; Song Y; Qiao X
Bioorg Med Chem; 2017 Jun; 25(12):3116-3126. PubMed ID: 28462840
[TBL] [Abstract][Full Text] [Related]
32. Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage.
Fortune JM; Osheroff N
J Biol Chem; 1998 Jul; 273(28):17643-50. PubMed ID: 9651360
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol: A novel type of topoisomerase II inhibitor.
Lee JH; Wendorff TJ; Berger JM
J Biol Chem; 2017 Dec; 292(51):21011-21022. PubMed ID: 29074616
[TBL] [Abstract][Full Text] [Related]
34. Effects of Secondary Metabolites from the Fungus Septofusidium berolinense on DNA Cleavage Mediated by Human Topoisomerase IIα.
Vann KR; Ekiz G; Zencir S; Bedir E; Topcu Z; Osheroff N
Chem Res Toxicol; 2016 Mar; 29(3):415-20. PubMed ID: 26894873
[TBL] [Abstract][Full Text] [Related]
35. Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.
Oestergaard VH; Giangiacomo L; Bjergbaek L; Knudsen BR; Andersen AH
J Biol Chem; 2004 Jul; 279(27):28093-9. PubMed ID: 15123700
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of Triphenylethylene-Naphthalimide Conjugates as topoisomerase-IIα inhibitor and HSA binder.
Rani S; Luxami V; Paul K
ChemMedChem; 2021 Jun; 16(11):1821-1831. PubMed ID: 33725393
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of inhibition of the ATPase domain of human topoisomerase IIα by 1,4-benzoquinone, 1,2-naphthoquinone, 1,4-naphthoquinone, and 9,10-phenanthroquinone.
Gurbani D; Kukshal V; Laubenthal J; Kumar A; Pandey A; Tripathi S; Arora A; Jain SK; Ramachandran R; Anderson D; Dhawan A
Toxicol Sci; 2012 Apr; 126(2):372-90. PubMed ID: 22218491
[TBL] [Abstract][Full Text] [Related]
38. 3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase IIα catalytic inhibitor with low DNA damage.
Park SE; Chang IH; Jun KY; Lee E; Lee ES; Na Y; Kwon Y
Eur J Med Chem; 2013 Nov; 69():139-45. PubMed ID: 24013413
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, biological evaluation, structure-activity relationship study, and mode of action of 2-phenol-4,6-dichlorophenyl-pyridines.
Shrestha A; Park S; Shin S; Man Kadayat T; Bist G; Katila P; Kwon Y; Lee ES
Bioorg Chem; 2018 Sep; 79():1-18. PubMed ID: 29715635
[TBL] [Abstract][Full Text] [Related]
40. Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha.
Syrovets T; Büchele B; Gedig E; Slupsky JR; Simmet T
Mol Pharmacol; 2000 Jul; 58(1):71-81. PubMed ID: 10860928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
